Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections


Journal article


Aldo AM Lima, Erico AG Arruda, Roberto J Pires-Neto, Melissa S Medeiros, J Quirino-Filho, Marco A Clementino, Rafhaella NDG Gondim, Lyvia MC Magalhaes, Kerene F Cavalcante, Vania AF Viana, others
medRxiv, Cold Spring Harbor Laboratory Press, 2021

Cite

Cite

APA   Click to copy
Lima, A. A. M., Arruda, E. A. G., Pires-Neto, R. J., Medeiros, M. S., Quirino-Filho, J., Clementino, M. A., … others. (2021). Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections. MedRxiv.


Chicago/Turabian   Click to copy
Lima, Aldo AM, Erico AG Arruda, Roberto J Pires-Neto, Melissa S Medeiros, J Quirino-Filho, Marco A Clementino, Rafhaella NDG Gondim, et al. “Clinical Trial of Efficacy and Toxicity of Disoproxil Tenofovir Fumarate and Emtricitabine for Mild to Moderate SARS-CoV-2 Infections.” medRxiv (2021).


MLA   Click to copy
Lima, Aldo A. M., et al. “Clinical Trial of Efficacy and Toxicity of Disoproxil Tenofovir Fumarate and Emtricitabine for Mild to Moderate SARS-CoV-2 Infections.” MedRxiv, Cold Spring Harbor Laboratory Press, 2021.


BibTeX   Click to copy

@article{lima2021a,
  title = {Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections},
  year = {2021},
  journal = {medRxiv},
  publisher = {Cold Spring Harbor Laboratory Press},
  author = {Lima, Aldo AM and Arruda, Erico AG and Pires-Neto, Roberto J and Medeiros, Melissa S and Quirino-Filho, J and Clementino, Marco A and Gondim, Rafhaella NDG and Magalhaes, Lyvia MC and Cavalcante, Kerene F and Viana, Vania AF and others}
}


Share


Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in